Literature DB >> 12823652

Underdiagnosis of depression in HIV: who are we missing?

Steven M Asch1, Amy M Kilbourne, Allen L Gifford, M Audrey Burnam, Barbara Turner, Martin F Shapiro, Samuel A Bozzette.   

Abstract

OBJECTIVE: To determine the sociodemographic and service delivery correlates of depression underdiagnosis in HIV.
DESIGN: Cross-sectional survey. PATIENTS/PARTICIPANTS: National probability sample of HIV-infected persons in care in the contiguous United States who have available medical record data.
MEASUREMENTS AND MAIN RESULTS: We interviewed patients using the Composite International Diagnostic Interview (CIDI) survey from the Mental Health Supplement. Patients also provided information regarding demographics, socioeconomic status, and HIV disease severity. We extracted patient medical record data between July 1995 and December 1997, and we defined depression underdiagnosis as a diagnosis of major depressive disorder based on the CIDI and no recorded depression diagnosis by their principal health care provider in their medical records between July 1995 and December 1997. Of the 1140 HIV Cost and Services Utilization Study patients with medical record data who completed the CIDI, 448 (37%) had CIDI-defined major depression, and of these, 203 (45%) did not have a diagnosis of depression documented in their medical record. Multiple logistic regression analysis revealed that patients who had less than a high school education (P <.05) were less likely to have their depression documented in the medical record compared to those with at least a college education. Patients with Medicare insurance coverage compared to those with private health insurance (P <.01) and those with >or=3 outpatient visits (P <.05) compared to <3 visits were less likely to have their depression diagnosis missed by providers.
CONCLUSIONS: Our results suggest that providers should be more attentive to diagnosing comorbid depression in HIV-infected patients.

Entities:  

Mesh:

Year:  2003        PMID: 12823652      PMCID: PMC1494868          DOI: 10.1046/j.1525-1497.2003.20938.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  53 in total

1.  National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample.

Authors:  M R Frankel; M F Shapiro; N Duan; S C Morton; S H Berry; J A Brown; M A Burnam; S E Cohn; D P Goldman; D F McCaffrey; S M Smith; P A St Clair; J F Tebow; S A Bozzette
Journal:  Health Serv Res       Date:  1999-12       Impact factor: 3.402

2.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  Mental health literacy: an impediment to the optimum treatment of major depression in the community.

Authors:  R D Goldney; L J Fisher; D H Wilson
Journal:  J Affect Disord       Date:  2001-05       Impact factor: 4.839

4.  Indinavir concentrations and St John's wort.

Authors:  S C Piscitelli; A H Burstein; D Chaitt; R M Alfaro; J Falloon
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

5.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

6.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

7.  A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness.

Authors:  D Gill; S Hatcher
Journal:  J Psychosom Res       Date:  1999-08       Impact factor: 3.006

8.  Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

Authors:  J R Ickovics; M E Hamburger; D Vlahov; E E Schoenbaum; P Schuman; R J Boland; J Moore
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

9.  Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

Authors:  S J Ferrando; J D Goldman; W E Charness
Journal:  Gen Hosp Psychiatry       Date:  1997-03       Impact factor: 3.238

10.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.

Authors:  P S Ciechanowski; W J Katon; J E Russo
Journal:  Arch Intern Med       Date:  2000-11-27
View more
  108 in total

1.  Reflections on the 10th anniversary of the AHCPR's guideline for the treatment of depression in primary care.

Authors:  Bruce L Rollman
Journal:  J Gen Intern Med       Date:  2003-06       Impact factor: 5.128

2.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

3.  Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial.

Authors:  Alexander C Tsai; Dan H Karasic; Gwendolyn P Hammer; Edwin D Charlebois; Kathy Ragland; Andrew R Moss; James L Sorensen; James W Dilley; David R Bangsberg
Journal:  Am J Public Health       Date:  2012-06-21       Impact factor: 9.308

Review 4.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  When "need plus supply" does not equal demand: challenges in uptake of depression treatment in HIV clinical care.

Authors:  Brian W Pence; E Byrd Quinlivan; Amy Heine; Malaika Edwards; Nathan M Thielman; Bradley N Gaynes
Journal:  Psychiatr Serv       Date:  2014-12-01       Impact factor: 3.084

6.  Risk factors for missed HIV primary care visits among men who have sex with men.

Authors:  Lara Traeger; Conall O'Cleirigh; Margie R Skeer; Kenneth H Mayer; Steven A Safren
Journal:  J Behav Med       Date:  2011-11-09

7.  Update on mental health issues in patients with HIV infection.

Authors:  Natalia Vlassova; Andrew F Angelino; Glenn J Treisman
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

8.  Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.

Authors:  Angela M Bengtson; Brian W Pence; Bradley N Gaynes; E Byrd Quinlivan; Amy D Heine; Julie K OʼDonnell; Heidi M Crane; W Christopher Mathews; Richard D Moore; Daniel Westreich; Conall OʼCleirigh; Katerina Christopoulos; Matthew J Mimiaga; Michael J Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

9.  The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.

Authors:  Bethany L DiPrete; Brian W Pence; Angela M Bengtson; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Riddhi Modi; Bradley N Gaynes
Journal:  AIDS Behav       Date:  2019-03

10.  Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California.

Authors:  Iman Parhami; Timothy W Fong; Aaron Siani; Claudia Carlotti; Homayoon Khanlou
Journal:  AIDS Behav       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.